DEA Sued Over Delays To Open Records For Psychedelics And Cannabis

By Joana Scopel The Drug Enforcement Administration (DEA) has been sued over a failure to reply in due time to requests for psychedelics and cannabis records, reported Marijuana Moment. This new suit centers on the DEA’s alleged “unlawful…

DEA Reports Uptick In Marijuana-Related Seizures & Arrests: Why Is This Happening? NORML Has An Idea

By Nicolás Jose Rodriguez Federal law enforcement brokers and their partners seized above 5.5 million cultivated cannabis crops and made much more than 6,600 cannabis-connected arrests in 2021, according to…

DEA Reports Ongoing Decline in Federal Pot Arrests

Federal regulation enforcement continues to make much less and much less arrests for weed, according to info produced by the Section of Justice, a pattern that dovetails with the new…

DEA Delays Production Of Marijuana Drug As Potential Treatment For MS And Huntington’s Disease

By Nina Zdinjak MMJ International Holdings, in collaboration with a specialty pharmaceutical options company, has been production gelatin capsule medications dependent on compounds discovered in cannabis. The company will investigate these in…

How The DEA Is Helping Parents Decode Emojis Used To Discuss Drugs

As a approach of battling back again towards overdose fatalities, the DEA just lately began the “One Tablet Can Kill” campaign. The driving supply of enthusiasm driving the new marketing…

DEA Presents Emoji Explanations for ‘One Pill Can Kill’ Campaign

In a campaign to teach dad and mom on the emoji discussions of their little ones in regards to drug use, the Drug Enforcement Administration (DEA) has created a legend…

DEA Raises Production Levels For Psychedelics, Deschedules Cocaine-Derived Drug — Could Cannabis Be Next?

By Nina Zdinjak The Drug Enforcement Administration (DEA) raised lawful creation quotas for unlawful Routine I medicine like psilocybin, MDMA and DMT…again. The agency very first established its first targets…

Doctor Sues DEA for Right to Give Psilocybin to Ailing Patients

Dr. Sunil Aggarwal Study into the use of psychedelics to handle PTSD, melancholy, addictions, and other situations is speedily getting momentum. At the forefront of this hard work are quite…

5 Reasons hemp companies should embrace DEA testing requirements

(Editor’s take note: This story is aspect of a recurring series of commentaries from professionals connected to the hemp market. Roger Brown is CEO and founder of ACS Laboratory in…